Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15319718 | 0.90 | OPRK1 (0.44) | OPRK1TSHRHTTHSD11B1CAPN1 | |
| SCHEMBL15319638 | 0.83 | OPRK1 (0.44) | OPRK1TSHRHTTHSD11B1CAPN1 | |
| SCHEMBL15319893 | 0.83 | USP2 (0.48) | OPRK1TSHRCAPN1HSD17B10KDM4E | |
| SCHEMBL541213 | 0.82 | CAPN1 (0.58) | HTTCAPN1KDM4EMAPTALDH1A1 | |
| SCHEMBL15320473 | 0.81 | ALDH1A1 (0.46) | OPRK1HTTHSD11B1CAPN1KDM4E | |
| SCHEMBL15320152 | 0.81 | OPRK1 (0.42) | OPRK1HTTHSD11B1CAPN1KDM4E | |
| SCHEMBL17793835 | 0.81 | HCRTR1 (0.52) | OPRK1TSHRHTTHSD11B1CAPN1 | |
| SCHEMBL29551266 | 0.81 | HCRTR1 (0.52) | OPRK1TSHRHTTHSD11B1CAPN1 | |
| SCHEMBL19481015 | 0.76 | TSHR (0.53) | OPRK1TSHRHTTHSD11B1HSD17B10 | |
| SCHEMBL541428 | 0.76 | CAPN1 (0.53) | OPRK1TSHRHTTHSD11B1CAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9150545-B2 | Carboxamide compounds and their use as calpain inhibitors V | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-10-06 | — | — | US | disclosed |
| US-20150065477-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-03-05 | — | — | US | disclosed |
| EP-2834230-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | AbbVie Deutschland GmbH & Co KG (DE) | 2015-02-11 | — | — | EP | disclosed |
| WO-2013149800-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | AbbVie Deutschland GmbH & Co. KG (DE) | 2013-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150065477-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | CAPN1, CAPN2, CAPNS1 | OPRK1 1615/4885TSHR 3262/4885HTT 840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.